In vitro effects of dietary inulin on human fecal microbiota and butyrate production

Journal of Microbiology and Biotechnology

Volumn 25, Issue 9, 2015, Pages 1555-1558

  Jung, Tae Hwan ^a   Jeon, Woo Min ^a   Han, Kyoung Sik ^a  

^a Sahmyook University   (South Korea)

Author keywords

Butyrate; Human fecal microbiota; In vitro fermentation; Inulin

Indexed keywords

BUTYRIC ACID; INULIN; PREBIOTIC AGENT; SHORT CHAIN FATTY ACID; BUTYRIC ACID DERIVATIVE;

ADULT; ARTICLE; BACTERIAL STRAIN; BATCH FERMENTATION; BIFIDOBACTERIUM; COLON; CONTROLLED STUDY; DIETARY FIBER; DIETARY INTAKE; ENTEROBACTERIACEAE; FECES MICROFLORA; HUMAN; IN VITRO STUDY; INTESTINE; LACTOBACILLUS; MALE; NORMAL HUMAN; BIOREACTOR; DRUG EFFECTS; FECES; FERMENTATION; INTESTINE FLORA; METABOLISM; MICROBIOLOGY; MICROFLORA;

BIOREACTORS; BUTYRATES; FECES; FERMENTATION; GASTROINTESTINAL MICROBIOME; HUMANS; INULIN; MICROBIOTA; PREBIOTICS;

EID: 84941914164     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.1505.05078     Document Type: Article

References (23)

1. Balan P, Han KS, Rutherfurd-Markwick K, Singh H, Moughan PJ. 2011. Ovine serum immunoglobulin has immunomodulatory effects in growing rats gavaged with Salmonella enteritidis. J. Nutr. 141: 950-956.
2. Castillo M, Martin-Orue SM, Roca M, Manzanilla EG, Badiola I, Perez JF, Gasa J. 2006. The response of gastrointestinal microbiota to avilamycin, butyrate, and plant extracts in early-weaned pigs. J. Anim. Sci. 84: 2725-2734.
3. Castillo M, Martin-Orue SM, Nofrarias M, Manzanilla EG, Gasa J. 2007. Changes in caecal microbiota and mucosal morphology of weaned pigs. Vet. Microbiol. 124: 239-247.
4. De Preter V, Falony G, Windey K, Hamer HM, De Vuyst L, Verbeke K. 2010. The prebiotic, oligofructose-enriched inulin modulates the faecal metabolite profile: an in vitro analysis. Mol. Nutr. Food Res. 54: 1791-1801.
5. Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, et al. 2013. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. USA 110: 9066-9071.
6. Ewing WN, Cole DJA. 1996. The living gut: an introduction to microorganisms in nutrition. Livest. Prod. Sci. 45: 221-222.
7. Forestier C, De Chams C, Vatoux C, Joly B. 2001. Probiotic activities of Lactobacillus casei rhamnosus: in vitro adherence to intestinal cells and antimicrobial properties. Res. Microbiol. 152: 167-173.
8. Fujiwara S, Hashiba H, Hirota T, Forstner JF. 1997. Proteinaceous factor(s) in culture supernatant fluids of Bifidobacterium which prevents the binding of enterotoxigenic Escherichia coli to gangliotetraosylceramide. Appl. Environ. Microbiol. 63: 506-512.
9. Guarner F. 2005. Inulin and oligofructose: impact on intestinal diseases and disorders. Br. J. Nutr. 93: S61-S65.
10. Han KS, Balan P, Molist Gasa F, Boland M. 2011. Green kiwifruit modulates the colonic microbiota in growing pigs. Lett. Appl. Microbiol. 52: 379-385.
11. Jenkins DJ, Kendall CW, Vuksan V. 1999. Inulin, oligofructose and intestinal function. J. Nutr. 129: 1431S-1433S.
12. Kim Y, Kim SH, Whang KY, Kim YJ, Oh S. 2008. Inhibition of Escherichia coli O157:H7 attachment by interactions between lactic acid bacteria and intestinal epithelial cells. J. Microbiol. Biotechnol. 18: 1278-1285.
13. Niness KR. 1999. Inulin and oligofructose: what are they? J. Nutr. 129 (7 Suppl): 1402S-1406S.
14. Ogawa M, Shimizu K, Nomoto K, Tanaka R, Hamabata T, Yamasaki S, et al. 2001. Inhibition of in vitro growth of Shiga toxin-producing Escherichia coli O157:H7 by probiotic Lactobacillus strains due to production of lactic acid. Int. J. Food Microbiol. 68: 135-140.
15. Ooi LG, Liong, MT. 2010. Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings. Int. J. Mol. Sci. 11: 2499-2522.
16. Pieper R, Jha R, Rossnagel B, Van Kessel AG, Souffrant WB, Leterme P. 2008. Effect of barley and oat cultivars with different carbohydrate compositions on the intestinal bacterial communities in weaned piglets. FEMS Microbiol. Ecol. 66: 556-566.
17. Rafter J, Bennett M, Caderni G, Clune Y, Hughes R, Karlsson PC, et al. 2007. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am. J. Clin. Nutr. 85: 488-496.
18. Roberfroid M. 2007. Prebiotics: the concept revisited. J. Nutr. 137: 830S-837S.
19. Roediger WEW. 1980. Role of anaerobic-bacteria in the metabolic welfare of the colonic mucosa in man. Gut 21: 793-798.
20. Seifert S, Watzl B. 2007. Inulin and oligofructose: a review of experimental data on immune modulation. J. Nutr. 137: S2563-S2567.
21. Topping DL, Fukushima M, Bird AR. 2003. Resistant starch as a prebiotic and symbiotic: state of the art. Proc. Nutr. Soc. 62: 171-176.
22. Verstegen MW, Williams BA. 2002. Alternatives to the use of antibiotics as growth promoters for monogastric animals. Anim. Biotechnol. 13: 113-127.
23. Wang X, Gibson GR. 1993. Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large-intestine. J. Appl. Bacteriol. 75: 373-380.